An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians (1998)

Author(s): G. C. Ibeanu, J. Blaisdell, B. I. Ghanayem, C. Beyeler, S. Benhamou, C. Bouchardy, G. R. Wilkinson, P. Dayer, A. K. Daly and J. A. Goldstein

      • Journal: Pharmacogenetics
      • Volume: 8
      • Pages: 129-135
      • Publication type: Article
      • Bibliographic status: Published

        Professor Ann Daly
        Professor of Pharmacogenetics and Associate Dean for Internationalisation (Faculty of Medical Sciences)